The multifaceted biology of PCSK9

NG Seidah, A Prat - Endocrine reviews, 2022 - academic.oup.com
This article reviews the discovery of PCSK9, its structure–function characteristics, and its
presently known and proposed novel biological functions. The major critical function of …

Targeting proprotein convertase subtilisin/kexin type 9 (PCSK9): from bench to bedside

X Bao, Y Liang, H Chang, T Cai, B Feng… - … and Targeted Therapy, 2024 - nature.com
Proprotein convertase subtilisin/kexin type 9 (PCSK9) has evolved as a pivotal enzyme in
lipid metabolism and a revolutionary therapeutic target for hypercholesterolemia and its …

The many roles of cholesterol in sepsis: a review

DA Hofmaenner, A Kleyman, A Press… - American journal of …, 2022 - atsjournals.org
The biological functions of cholesterol are diverse, ranging from cell membrane integrity, cell
membrane signaling, and immunity to the synthesis of steroid and sex hormones, vitamin D …

[HTML][HTML] Targeting PCSK9 to tackle cardiovascular disease

S Hummelgaard, JP Vilstrup, C Gustafsen… - Pharmacology & …, 2023 - Elsevier
Lowering blood cholesterol levels efficiently reduces the risk of developing atherosclerotic
cardiovascular disease (ASCVD), including coronary artery disease (CAD), which is the …

Proprotein convertase subtilisin/kexin type 9 (PCSK9) in the central nervous system

AS Bell, J Wagner, DB Rosoff, FW Lohoff - Neuroscience & Biobehavioral …, 2023 - Elsevier
The gene encoding proprotein convertase subtilisin/kexin type 9 (PCSK9) and its protein
product have been widely studied for their role in cholesterol and lipid metabolism. PCSK9 …

PCSK9 promotes endothelial dysfunction during sepsis via the TLR4/MyD88/NF-κB and NLRP3 pathways

L Huang, Y Li, Z Cheng, Z Lv, S Luo, Y Xia - Inflammation, 2023 - Springer
Endothelial dysfunction often accompanies sepsis. We aimed to explore the role of PCSK9
in septic endothelial dysfunction. Sepsis was induced by lipopolysaccharide (LPS) treatment …

Plasma Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) as a possible biomarker for severe COVID-19

P Mester, P Amend, S Schmid, M Müller, C Buechler… - Viruses, 2023 - mdpi.com
Proprotein convertase subtilisin/kexin type 9 (PCSK9) reduces low density lipoprotein (LDL)
uptake, leading to increased plasma levels of LDL. In addition, PCSK9 has been implicated …

TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real‐World Clinical Results

AL Dickson, LL Daniel, J Zanussi… - Clinical …, 2022 - Wiley Online Library
Azathioprine is used frequently to treat several inflammatory conditions. However, treatment
is limited by adverse events—in particular, myelotoxicity. Thiopurine‐S‐methyltransferase …

PCSK9: a potential therapeutic target for sepsis

Y Yuan, W Wu, S Sun, Y Zhang… - Journal of immunology …, 2020 - Wiley Online Library
Sepsis is a life‐threatening organ dysfunction syndrome caused by a dysregulated host
response to infection. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is often …

A Mendelian randomization approach using 3-HMG-coenzyme-A reductase gene variation to evaluate the association of statin-induced low-density lipoprotein …

G Liu, M Shi, JD Mosley, C Weng, Y Zhang… - JAMA network …, 2021 - jamanetwork.com
Importance Observational studies suggest that statins, which inhibit 3-hydroxy-3-
methylglutaryl coenzyme A (HMG-CoA) reductase, may be associated with beneficial effects …